On June 11, 2026, the 3rd Global MedTech Conference was held at the Beijing Zhongguancun Exhibition Center Conference Hall. Co-hosted by MedChina (Siyu MedTech) and the Zhongguancun United Innovative Biomedical Industry Alliance, the event was co-organized by Beijing Zhongguancun Science City Innovation and Development Co., Ltd., Beijing Zhongguancun Science City Innovation and Technology Service Co., Ltd., China Beijing (Haidian) Overseas Chinese Scholars Pioneer Park, and TusStar Medical-Engineering Interdisciplinary Innovation Center. The conference attracted over 600 professional guests from government agencies, medical institutions, universities and research institutes, investment organizations, and medical device enterprises. Discussions centered on hot topics including innovative medical devices, technology transfer, industrial innovation, and international development. Two industry white papers were released, the 4th Plastic Surgery Innovation and Transformation Competition was launched, and the 2026 Global MedTech Innovation Awards were presented.

Opening: Spotlight on Innovation and Technology Transfer

At the opening ceremony, Qi Zuoliang, former President of the Plastic Surgery Hospital, Chinese Academy of Medical Sciences, delivered the first address. He stated that medical technology innovation is entering a new stage that places greater emphasis on clinical value and technology transfer, and expressed hope that deeper collaboration among industry, academia, research, and medicine would drive more innovative achievements toward clinical application.

Zhang Jian, Section Chief of Industry Division III, Zhongguancun Science City Management Committee, delivered an address introducing the development of the biomedical industry in Haidian District. He noted that Haidian is continuously improving its innovation ecosystem, promoting the development of medical devices, innovative pharmaceuticals, and frontier medical technologies, and providing a better industrial environment for the growth of innovative enterprises.

Innovation Awards Unveiled, Honoring Industry Innovation

The 2026 Global MedTech Innovation Awards ceremony was held on-site.

The Global MedTech Innovation Awards focus on innovative device R&D, clinical application innovation, and technology transfer practices, recognizing enterprises and institutions that have achieved outstanding performance in the medical technology field over the past year.

Among the Global MedTech Innovation Awards, the following enterprises were honored: Beijing PINS Medical Co., Ltd., Beijing Tonghe Litai Biotechnology Co., Ltd., SinoVision Technology (Beijing) Co., Ltd., Qingdao Haier Biomedical Co., Ltd., Shanghai United Imaging Healthcare Co., Ltd., Chengdu NOVEL MEDICAL Equipment Co., Ltd., GenLight MedTech Ltd., Ambulanc (Shenzhen) Tech. Co., Ltd., Shenzhen Zhongke Jingcheng Medical Technology Co., Ltd., and Hunan Antitumor and Health Reconstruction Biotechnology Co., Ltd.

Meanwhile, the 2026 Global Ophthalmology Innovation Awards and the 2026 Global Cardiovascular Innovation Awards were also presented, recognizing representative innovative enterprises, medical institutions, and innovative achievements in the ophthalmology and cardiovascular fields.

4th Plastic Surgery Innovation and Transformation Competition Launched

During the conference, the 4th Plastic Surgery Innovation and Transformation Competition was officially launched.

He Jiantao, Chairman of Beijing Zhongguancun Life and Health Industry Service Co., Ltd., introduced the competition. Subsequently, Qi Zuoliang, former President of the Plastic Surgery Hospital, Chinese Academy of Medical Sciences, and Yao Guijin, Director of the Badachu Plastic Surgery Medical Concept Verification Center, jointly participated in the launch ceremony.

The Plastic Surgery Innovation and Transformation Competition, initiated by the Plastic Surgery Hospital, Chinese Academy of Medical Sciences, aims to promote the transfer of medical innovation achievements, foster deep integration between clinical needs and industrial innovation, and build an exchange and collaboration platform among physicians, research teams, and industry.

Two White Papers Officially Released

During the white paper release session, Zhao Qing, Founder of MedChina (Siyu MedTech) and Secretary-General of the Zhongguancun United Innovative Biomedical Industry Alliance, officially released the China Innovative Medical Devices White Paper 2026 and delivered a keynote presentation titled "Others' Answers, or Our Own Questions — The Next Chapter of China's Medical Device Innovation."

Based on long-term tracking research in the innovative medical devices field, this white paper systematically reviews the development status of China's innovative medical devices, registration and approval trends, and industrial landscape.

Subsequently, Yao Guijin, Director of the Badachu Plastic Surgery Medical Concept Verification Center, released the Medical Innovation and Transformation White Paper 2026, sharing insights on pathways for medical technology transfer, concept verification system construction, and innovation and transformation practices.

Technology Innovation and Technology Transfer: Multi-Dimensional Exploration by Hospitals, Industry, and Capital

Entering the main forum, Liu Hui, Director of the Beijing Medical and Health Technology Development Center, shared insights on policies related to Beijing's medical and health industry and medical devices, introducing the latest developments in innovative medical devices, technology transfer, industrial support, and innovation ecosystem construction in Beijing.

Yu Yang, Vice President of Beijing Jishuitan Hospital, Capital Medical University, delivered a keynote presentation titled "Technology Innovation Driving High-Quality Hospital Development." Drawing on the hospital's practical experience, she introduced the important role of technology innovation in discipline development, technology transfer, and high-quality hospital development, and shared the hospital's explorations in promoting the implementation of innovative achievements.

Wang Zaizun, Chief Analyst of Medical Devices at CITIC Securities, Co-Chief Analyst of Healthcare, and Analyst at the Future Industry Research Institute, delivered a keynote presentation titled "From Domestic Substitution to Innovation Leadership: A New Journey for the Internationalization of Chinese Medical Devices." He argued that as domestic innovation capabilities continue to improve, Chinese medical device enterprises are gradually moving from domestic substitution to global market competition, and that internationalization has become an important direction for industry development.

Liu Lijun, General Manager Assistant of the China Technology Exchange, delivered a keynote presentation titled "Compliance Pathways for Medical Technology Transfer." Using practical cases, he introduced key issues around achievement confirmation, intellectual property management, technology transactions, and critical considerations during the technology transfer process, providing reference for the standardized transfer of medical technology achievements.

Xie Zhijian, Chief Product Officer of Qingdao Haier Biomedical Co., Ltd., delivered a keynote presentation titled "Smart Pharmacy Going Global: From Equipment Export to System Adaptation." Drawing on the company's internationalization experience, he shared the development pathway from single equipment export to system solution delivery, as well as the experiences and reflections of Chinese medical technology enterprises participating in global competition.

Wang Zhuangzhi, Vice President and CMO of Hangzhou Artery Planner Technology Co., Ltd., delivered a keynote presentation titled "Annual Check-ups for Blood Vessels — How Artery Planner Helps Everyone Avoid Myocardial Infarction 10 Years Earlier, Ending the Old Era of 'Waiting for the Disease to Strike.'" He introduced the development of non-invasive functional assessment technologies and shared the clinical application value of innovative technologies such as FFR-CT in early screening and risk assessment for coronary heart disease.

The morning session presented diverse perspectives on the innovative development of the medical technology industry, from hospital innovation system construction and technology transfer pathways to internationalization development trends, and provided new reflections on how innovative achievements can achieve industrial implementation.

Afternoon Session: From Biomaterials to Global Registration, Exploring New Pathways for Medical Technology Innovation

The afternoon session was moderated by Cui Jing, Founding Partner of Jiuhao Capital, focusing on hot directions including biomaterials, surgical robots, artificial intelligence, technology transfer, and international registration. Multiple guests from research institutions, enterprises, and industry research organizations shared their latest observations and practical experiences in their respective fields.

Li Yi, Deputy Director of the Functional Materials Institute at the Yangtze River Delta National Innovation Center, delivered a keynote presentation titled "Biomaterial Innovation Breaking Through: Integrating Industry Chains to Empower High-Value Medical Device Transfer and Implementation." She stated that biomaterials are an important foundation for high-end medical device innovation, and that their R&D involves not only breakthroughs in the materials themselves but also the integration of multiple links including R&D, verification, production, and clinical application. Focusing on industry chain collaboration and innovation resource integration, Li Yi shared practical experiences in promoting the transfer and implementation of biomaterial achievements.

Ye Jing, Chief Analyst of Healthcare at Northeast Securities, delivered a keynote presentation titled "Laparoscopic Robot Industry's Dual Breakthrough: From Domestic Substitution to Global Competition." Combining industry data and market development trends, she analyzed the rapid growth of domestic laparoscopic surgical robots in recent years and argued that as technology maturity improves and commercialization accelerates, domestic enterprises are gradually moving from local market competition to global deployment.

Xu Shuhan, Vice President of Ronghe Medical, delivered a keynote presentation titled "From 'Black Box' to Visualized Treatment: How Real-Time Electromagnetic Navigation Pulsed Ablation Is Reshaping COPD Interventional Therapy." She introduced the application progress of combining real-time electromagnetic navigation with pulsed electric field technology in chronic obstructive pulmonary disease (COPD) interventional therapy, and shared exploration results in precision positioning, treatment efficiency, and clinical safety.

Zhang Minghao, Vice President of Heiyu Science, delivered a keynote presentation titled "R&D and Application of AI Fully Automated Equipment for Intelligent Organoid Manufacturing." Focusing on the engineering and standardization development of organoid technology, he introduced the R&D concept of the DSO intelligent organoid integrated platform and the application value of AI automated equipment in improving organoid preparation efficiency and consistency.

Liu Haoran, Engineer at the Cloud Computing and Digitalization Research Institute of the China Academy of Information and Communications Technology, delivered a keynote presentation titled "Medical Device Innovation Practices from the Perspective of the 'Open Competition' Mechanism." She analyzed changes in the organization of innovation tasks in the medical device field under the national "open competition" mechanism in recent years, as well as practical cases of enterprises and research institutions participating in major science and technology project tackling.

Yin Nan, Innovation Product Director of SinoVision Technology (Beijing) Co., Ltd., delivered a keynote presentation titled "From Following to Leading: The Breakthrough and New Journey of Domestic CT Imaging." Reviewing the development history of domestic CT imaging equipment, he introduced the clinical application of innovative products such as standing CT, specialized orthopedic joint CT, and 3D intelligent imaging platforms, and shared the development pathway of domestic medical imaging equipment from technology catch-up to innovation breakthrough.

Cui Yingying, Founder and CEO of Meichuanghe, delivered a keynote presentation titled "The 'Fast Track' to Global Innovation: From US/EU Innovation Designation to Efficient Approval." Combining recent changes in the international regulatory environment, she systematically reviewed new trends in innovation designation and registration approval for major markets such as the United States and the European Union, and shared experiences and challenges in international registration and global deployment.

Gao Guifeng, Vice President of the Research Institute of Ambulanc (Shenzhen) Tech. Co., Ltd., delivered a keynote presentation titled "Medical-Engineering Integration Empowering Emergency and Critical Care: Frontier Technology Innovation Practices and Transfer Applications." He introduced the company's technological innovation achievements in the emergency and life support fields, as well as the application practices of related products in pre-hospital emergency care, in-hospital treatment, and emergency medical rescue scenarios.

Wang Bing, Partner at Beijing Qiangheng Law Firm, delivered a keynote presentation titled "Ownership Risks in Medical and Health Technology Transfer: Observations and Recommendations Based on Practical Cases." Combining multiple technology transfer cases, he analyzed issues around intellectual property ownership, revenue distribution, and cooperation mechanism design, providing practical reference for medical institutions and research teams engaged in technology transfer.

As the final speaker, Chen Fuyan, Product Marketing Manager of Chengdu NOVEL MEDICAL Equipment Co., Ltd., delivered a keynote presentation titled "Breakthroughs and Innovation in China's Nuclear Medicine Single-Photon Imaging Technology." She shared the development and application of single-photon imaging technology and introduced related innovation progress in the domestic nuclear medicine equipment field.

Focusing on Innovation Implementation, Discussing the Future of the Industry

From innovative medical devices to technology transfer, from hospital innovation system construction to globalization pathways, from biomaterials and artificial intelligence to surgical robots and nuclear medicine imaging, the 3rd Global MedTech Conference showcased the latest explorations and practices of China's medical technology industry.

During the conference, the Innovative Medical Device Awards, Ophthalmology Innovation Awards, and Cardiovascular Innovation Awards were announced successively; the China Innovative Medical Devices White Paper 2026 and the Medical Innovation and Transformation White Paper 2026 were officially released; and the 4th Plastic Surgery Innovation and Transformation Competition was launched simultaneously. Guests engaged in in-depth exchanges on multiple topics including innovative device R&D, technology transfer, and industrial collaborative development.

With this, the 3rd Global MedTech Conference concluded successfully. As innovation capabilities continue to improve and the industrial ecosystem is continuously refined, how to drive more innovative achievements toward clinical transfer, industrial implementation, and further expansion into global markets will become a critical agenda item.

June 11, 2026